Kwangdong Healthbio Co., Ltd. (XKON:086220)
South Korea · Delayed Price · Currency is KRW 1,199.00
+99.00 (9.00%)
At close: Nov 13, 2026
Kwangdong Healthbio Market Cap
Kwangdong Healthbio has a market cap or net worth of 15.21 billion as of November 13, 2026. It is the 41,045th most valuable company in the world and the 2,547th biggest in South Korea. Its market cap has increased by 5.02% in one year.
Market Cap
15.21B
Enterprise Value
n/a
Revenue
38.10B
Global Rank
Country Rank
#2,547 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2017, Kwangdong Healthbio's market cap has decreased from 20.68B to 15.21B, a decrease of -26.42%. That is a compound annual growth rate of -3.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 15.21B | -23.82% |
| Dec 30, 2025 | 19.97B | 14.12% |
| Dec 30, 2024 | 17.50B | -38.70% |
| Dec 28, 2023 | 28.55B | 23.01% |
| Dec 29, 2022 | 23.21B | -12.02% |
| Dec 30, 2021 | 26.38B | -4.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmsville | 25.89B |
| Baskhanbio Pharma | 24.49B |
| Seoul Pharma | 20.40B |
| Daesung Microbiological Labs. | 20.14B |
| Union Korea Pharm | 19.70B |
| BIFIDO | 19.30B |
| WooGene B&G | 19.06B |
| Hurum | 18.70B |